APO Research
Talk to an analyst

APO RESEARCH · REPORT

Niraparib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Niraparib Industry Growth and Trends Forecast to 2032

23 December 202571 pages

Choose your research edition.

Industry ResearchNiraparib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Niraparib Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Niraparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niraparib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Niraparib Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Niraparib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Niraparib include TESARO and Everest Pharmaceuticals Limited among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Niraparib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Niraparib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Niraparib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Niraparib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Niraparib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Niraparib Market by Company

TESARO

Everest Pharmaceuticals Limited

Niraparib Segment by Type

100mg*30 Capsules

100mg*60 Capsules

100mg*90 Capsules

Niraparib Segment by Application

Primary Peritoneal Cancer

Fallopian Tube Cancer

Recurrent Epithelial Ovarian Cancer

Others

Niraparib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niraparib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Niraparib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Niraparib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg*30 Capsules Table 2. Major Company of 100mg*60 Capsules Table 3. Major Company of 100mg*90 Capsules Table 4. Global Niraparib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Niraparib Sales by Type (2021-2026) & (k pcs) Table 6. Global Niraparib Sales Market Share in Volume by Type (2021-2026) Table 7. Global Niraparib Sales by Type (2021-2026) & (US$ Million) Table 8. Global Niraparib Sales Market Share in Value by Type (2021-2026) Table 9. Global Niraparib Price by Type (2021-2026) & (US$/pcs) Table 10. Global Niraparib Sales by Type (2027-2032) & (k pcs) Table 11. Global Niraparib Sales Market Share in Volume by Type (2027-2032) Table 12. Global Niraparib Sales by Type (2027-2032) & (US$ Million) Table 13. Global Niraparib Sales Market Share in Value by Type (2027-2032) Table 14. Global Niraparib Price by Type (2027-2032) & (US$/pcs) Table 15. North America Niraparib Sales by Type (2021-2026) & (k pcs) Table 16. North America Niraparib Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Niraparib Sales by Type (2021-2026) & (k pcs) Table 18. Europe Niraparib Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Niraparib Sales by Type (2021-2026) & (k pcs) Table 20. Asia-Pacific Niraparib Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Niraparib Sales by Type (2021-2026) & (k pcs) Table 22. Latin America Niraparib Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Niraparib Sales by Type (2021-2026) & (k pcs) Table 24. Middle East and Africa Niraparib Sales by Type (2021-2026) & (US$ Million) Table 25. Niraparib Industry Trends Table 26. Niraparib Industry Drivers Table 27. Niraparib Industry Opportunities and Challenges Table 28. Niraparib Industry Restraints Table 29. Global Niraparib Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Niraparib Revenue Market Share by Company (2021-2026) Table 31. Global Niraparib Sales by Company (2021-2026) & (k pcs) Table 32. Global Niraparib Sales Share by Company (2021-2026) Table 33. Global Niraparib Market Price by Company (2021-2026) & (US$/pcs) Table 34. Global Niraparib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Niraparib Major Company Production Sites and Headquarters Table 36. Global Niraparib Company, Product Type & Application Table 37. Global Niraparib Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Niraparib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Niraparib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Niraparib Sales by Region (2021-2026) & (k pcs) Table 42. Global Niraparib Sales Market Share in Volume by Region (2021-2026) Table 43. Global Niraparib Sales by Region (2021-2026) & (US$ Million) Table 44. Global Niraparib Sales Market Share in Value by Region (2021-2026) Table 45. Global Niraparib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 46. Global Niraparib Sales by Region (2027-2032) & (k pcs) Table 47. Global Niraparib Sales Market Share in Volume by Region (2027-2032) Table 48. Global Niraparib Sales by Region (2027-2032) & (US$ Million) Table 49. Global Niraparib Sales Market Share in Value by Region (2027-2032) Table 50. Global Niraparib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 51. Global Niraparib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Niraparib Sales by Application (2021-2026) & (k pcs) Table 53. Global Niraparib Sales Market Share in Volume by Application (2021-2026) Table 54. Global Niraparib Sales by Application (2021-2026) & (US$ Million) Table 55. Global Niraparib Sales Market Share in Value by Application (2021-2026) Table 56. Global Niraparib Price by Application (2021-2026) & (US$/pcs) Table 57. Global Niraparib Sales by Application (2027-2032) & (k pcs) Table 58. Global Niraparib Sales Market Share in Volume by Application (2027-2032) Table 59. Global Niraparib Sales by Application (2027-2032) & (US$ Million) Table 60. Global Niraparib Sales Market Share in Value by Application (2027-2032) Table 61. Global Niraparib Price by Application (2027-2032) & (US$/pcs) Table 62. North America Niraparib Sales by Application (2021-2026) & (k pcs) Table 63. North America Niraparib Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Niraparib Sales by Application (2021-2026) & (k pcs) Table 65. Europe Niraparib Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Niraparib Sales by Application (2021-2026) & (k pcs) Table 67. Asia-Pacific Niraparib Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Niraparib Sales by Application (2021-2026) & (k pcs) Table 69. Latin America Niraparib Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Niraparib Sales by Application (2021-2026) & (k pcs) Table 71. Middle East and Africa Niraparib Sales by Application (2021-2026) & (US$ Million) Table 72. TESARO Company Information Table 73. TESARO Business Overview Table 74. TESARO Niraparib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 75. TESARO Niraparib Product Portfolio Table 76. TESARO Recent Development Table 77. Everest Pharmaceuticals Limited Company Information Table 78. Everest Pharmaceuticals Limited Business Overview Table 79. Everest Pharmaceuticals Limited Niraparib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 80. Everest Pharmaceuticals Limited Niraparib Product Portfolio Table 81. Everest Pharmaceuticals Limited Recent Development Table 82. North America Niraparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 83. North America Niraparib Sales by Country (2021-2026) & (k pcs) Table 84. North America Niraparib Sales Market Share by Country (2021-2026) Table 85. North America Niraparib Sales Forecast by Country (2027-2032) & (k pcs) Table 86. North America Niraparib Sales Market Share Forecast by Country (2027-2032) Table 87. North America Niraparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Niraparib Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Niraparib Market Share by Country (2021-2026) Table 90. North America Niraparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Niraparib Market Share Forecast by Country (2027-2032) Table 92. Europe Niraparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 93. Europe Niraparib Sales by Country (2021-2026) & (k pcs) Table 94. Europe Niraparib Sales Market Share by Country (2021-2026) Table 95. Europe Niraparib Sales Forecast by Country (2027-2032) & (k pcs) Table 96. Europe Niraparib Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Niraparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Niraparib Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Niraparib Market Share by Country (2021-2026) Table 100. Europe Niraparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Niraparib Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Niraparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Niraparib Sales by Country (2021-2026) & (k pcs) Table 104. Asia-Pacific Niraparib Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Niraparib Sales Forecast by Country (2027-2032) & (k pcs) Table 106. Asia-Pacific Niraparib Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Niraparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Niraparib Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Niraparib Market Share by Country (2021-2026) Table 110. Asia-Pacific Niraparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Niraparib Market Share Forecast by Country (2027-2032) Table 112. Latin America Niraparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 113. Latin America Niraparib Sales by Country (2021-2026) & (k pcs) Table 114. Latin America Niraparib Sales Market Share by Country (2021-2026) Table 115. Latin America Niraparib Sales Forecast by Country (2027-2032) & (k pcs) Table 116. Latin America Niraparib Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Niraparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Niraparib Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Niraparib Market Share by Country (2021-2026) Table 120. Latin America Niraparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Niraparib Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Niraparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Niraparib Sales by Country (2021-2026) & (k pcs) Table 124. Middle East and Africa Niraparib Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Niraparib Sales Forecast by Country (2027-2032) & (k pcs) Table 126. Middle East and Africa Niraparib Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Niraparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Niraparib Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Niraparib Market Share by Country (2021-2026) Table 130. Middle East and Africa Niraparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Niraparib Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Niraparib Distributors List Table 135. Niraparib Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Niraparib Image Figure 2. Global Niraparib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niraparib Market Size (2021-2032) & (US$ Million) Figure 4. Global Niraparib Sales (2021-2032) & (k pcs) Figure 5. 100mg*30 Capsules Image Figure 6. Global 100mg*30 Capsules Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 100mg*60 Capsules Image Figure 8. Global 100mg*60 Capsules Sales YoY Growth (2021-2032) & (k pcs) Figure 9. 100mg*90 Capsules Image Figure 10. Global 100mg*90 Capsules Sales YoY Growth (2021-2032) & (k pcs) Figure 11. Global Niraparib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Niraparib Market Share by Type 2025 VS 2032 Figure 13. North America Niraparib Sales Market Share in Volume by Type in 2025 Figure 14. North America Niraparib Sales Market Share in Value by Type in 2025 Figure 15. Europe Niraparib Sales Market Share in Volume by Type in 2025 Figure 16. Europe Niraparib Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Niraparib Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Niraparib Sales Market Share in Value by Type in 2025 Figure 19. Latin America Niraparib Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Niraparib Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Niraparib Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Niraparib Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Niraparib Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Primary Peritoneal Cancer Image Figure 26. Global Primary Peritoneal Cancer Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Fallopian Tube Cancer Image Figure 28. Global Fallopian Tube Cancer Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Recurrent Epithelial Ovarian Cancer Image Figure 30. Global Recurrent Epithelial Ovarian Cancer Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 33. Global Niraparib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Niraparib Market Share by Application 2025 VS 2032 Figure 35. North America Niraparib Sales Market Share in Volume by Application in 2025 Figure 36. North America Niraparib Sales Market Share in Value by Application in 2025 Figure 37. Europe Niraparib Sales Market Share in Volume by Application in 2025 Figure 38. Europe Niraparib Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Niraparib Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Niraparib Sales Market Share in Value by Application in 2025 Figure 41. Latin America Niraparib Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Niraparib Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Niraparib Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Niraparib Sales Market Share in Value by Application in 2025 Figure 45. North America Niraparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 46. North America Niraparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Niraparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Niraparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Niraparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 50. Europe Niraparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Niraparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Niraparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Niraparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 54. Asia-Pacific Niraparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Niraparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Niraparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Niraparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 58. Latin America Niraparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Niraparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Niraparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Niraparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 62. Middle East and Africa Niraparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Niraparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Niraparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Niraparib Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Niraparib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg*30 Capsules
  • 100mg*60 Capsules
  • 100mg*90 Capsules
Applications
  • Primary Peritoneal Cancer
  • Fallopian Tube Cancer
  • Recurrent Epithelial Ovarian Cancer
  • Others
Companies covered
  • TESARO
  • Everest Pharmaceuticals Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Niraparib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Niraparib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Niraparib Market by Type
  6. 1.3.1 100mg*30 Capsules
  7. 1.3.2 100mg*60 Capsules
  8. 1.3.3 100mg*90 Capsules
  9. 1.4 Global Niraparib Market Size by Type
  10. 1.4.1 Global Niraparib Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Niraparib Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Niraparib Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Niraparib Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Niraparib Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Niraparib Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Niraparib Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Niraparib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Niraparib Industry Trends
  2. 2.2 Niraparib Industry Drivers
  3. 2.3 Niraparib Industry Opportunities and Challenges
  4. 2.4 Niraparib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Niraparib Revenue (2021-2026)
  2. 3.2 Global Top Players by Niraparib Sales (2021-2026)
  3. 3.3 Global Top Players by Niraparib Price (2021-2026)
  4. 3.4 Global Niraparib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Niraparib Major Company Production Sites & Headquarters
  6. 3.6 Global Niraparib Company, Product Type & Application
  7. 3.7 Global Niraparib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Niraparib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Niraparib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Niraparib Tier 1, Tier 2, and Tier 3
4 Niraparib Regional Status and Outlook
  1. 4.1 Global Niraparib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Niraparib Historic Market Size by Region
  3. 4.2.1 Global Niraparib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Niraparib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Niraparib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Niraparib Forecasted Market Size by Region
  7. 4.3.1 Global Niraparib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Niraparib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Niraparib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Niraparib by Application
  1. 5.1 Niraparib Market by Application
  2. 5.1.1 Primary Peritoneal Cancer
  3. 5.1.2 Fallopian Tube Cancer
  4. 5.1.3 Recurrent Epithelial Ovarian Cancer
  5. 5.1.4 Others
  6. 5.2 Global Niraparib Market Size by Application
  7. 5.2.1 Global Niraparib Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Niraparib Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Niraparib Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Niraparib Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Niraparib Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Niraparib Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Niraparib Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Niraparib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TESARO
  2. 6.1.1 TESARO Company Information
  3. 6.1.2 TESARO Business Overview
  4. 6.1.3 TESARO Niraparib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TESARO Niraparib Product Portfolio
  6. 6.1.5 TESARO Recent Developments
  7. 6.2 Everest Pharmaceuticals Limited
  8. 6.2.1 Everest Pharmaceuticals Limited Company Information
  9. 6.2.2 Everest Pharmaceuticals Limited Business Overview
  10. 6.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Everest Pharmaceuticals Limited Niraparib Product Portfolio
  12. 6.2.5 Everest Pharmaceuticals Limited Recent Developments
7 North America by Country
  1. 7.1 North America Niraparib Sales by Country
  2. 7.1.1 North America Niraparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Niraparib Sales by Country (2021-2026)
  4. 7.1.3 North America Niraparib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Niraparib Market Size by Country
  6. 7.2.1 North America Niraparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Niraparib Market Size by Country (2021-2026)
  8. 7.2.3 North America Niraparib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Niraparib Sales by Country
  2. 8.1.1 Europe Niraparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Niraparib Sales by Country (2021-2026)
  4. 8.1.3 Europe Niraparib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Niraparib Market Size by Country
  6. 8.2.1 Europe Niraparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Niraparib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Niraparib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Niraparib Sales by Country
  2. 9.1.1 Asia-Pacific Niraparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Niraparib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Niraparib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Niraparib Market Size by Country
  6. 9.2.1 Asia-Pacific Niraparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Niraparib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Niraparib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Niraparib Sales by Country
  2. 10.1.1 South America Niraparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Niraparib Sales by Country (2021-2026)
  4. 10.1.3 South America Niraparib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Niraparib Market Size by Country
  6. 10.2.1 South America Niraparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Niraparib Market Size by Country (2021-2026)
  8. 10.2.3 South America Niraparib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Niraparib Sales by Country
  2. 11.1.1 Middle East and Africa Niraparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Niraparib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Niraparib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Niraparib Market Size by Country
  6. 11.2.1 Middle East and Africa Niraparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Niraparib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Niraparib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Niraparib Value Chain Analysis
  2. 12.1.1 Niraparib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Niraparib Production Mode & Process
  7. 12.2 Niraparib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Niraparib Distributors
  10. 12.2.3 Niraparib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst